Sophia Genetics is a data-driven medicine software company that provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. It offers a cloud-based platform, the SOPHiA DDM Platform, powered by AI and machine learning, to standardize, compute, and analyze digital health data, generating insights to improve diagnosis, therapy selection, analysis, and drug development.

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

COM:SOPHIAGENETICS

Sophia Genetics

Last Close

3.60

28/10 14:45

Market Cap

299.42M

Beta: -

Volume Today

2.75K

Avg: -

market

industry

website

crunchbase

ipo date

peer of

Metrics